MMRC Names MDS Pharma Services as Preferred CRO
News Apr 13, 2006
In this role, MDS Pharma Services will manage and execute MMRC pre-clinical and clinical research efforts, including data management related to the tissue accrual into the MMRC Tissue Bank.
The MMRC will also recommend MDS Pharma Services to industry partners as additional protocols are brought through the Consortium.
"MDS Pharma Services offers a full spectrum of advanced scientific and technological expertise to significantly accelerate each step of the drug discovery and development pathways," said Nancy Sumberaz, President, the MMRC.
"We are proud to consider MDS Pharma Services a true partner in our efforts to bring new therapeutic options to patients as quickly as possible."
"MDS Pharma Services is honored to have been chosen by the MMRC and we are ready to bring our global capabilities and oncology expertise to bear on the effort to fight multiple myeloma," says Alan Morgan, Vice President and General Manager for Global Clinical Development, MDS Pharma Services.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
Tuberculosis: Pharmacists Develop Substance to Counteract Antimicrobial ResistanceNews
Antimicrobial resistance is on the rise worldwide. This is becoming a problem for infectious diseases like tuberculosis as there are only a few active substances available to combat such diseases. Pharmacists have now found a way to increase the efficacy of a common tuberculosis agent while, at the same time, reducing resistance to it.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018